Sigilon: Sigilon Therapeutics, Inc.(NasdaqGS:SGTX) dropped from S&P TMI Index
(marketscreener.com) Sigilon Therapeutics, Inc. dropped from S&P TMI Indexhttps://www.marketscreener.com/quote/stock/SIGILON-THERAPEUTICS-INC-116081124/news/Sigilon-Therapeutics-Inc-NasdaqGS-SGTX-dropped-from-S-P-TMI-Index-44585507/?utm_medium=RSS&utm_content=20230811
Read full article »
Sigilon is a Massachusetts-based biopharmaceutical company that researches and develops cell therapies for the treatment of chronic diseases.
Read more